Staar Surgical (STAA) Price to Sales (2010 - 2026)

Staar Surgical (STAA) has reported Price to Sales for 17 consecutive years, with 14.89 the latest figure, recorded in Q3 2026.

• For the quarter ending Q3 2026, Price to Sales fell 21.27% year-over-year to 14.89; the trailing twelve-month figure through Jul 2026 stood at 4.1 (up 9.82% YoY), and the FY2026 full-year result was 4.87, up 28.08% from the prior year.
• Price to Sales grew to 14.89 in Q3 2026 per STAA's latest filing, from 10.76 in the prior quarter.
• Across five years, Price to Sales topped out at 122.56 in Q4 2022 and bottomed at 10.76 in Q2 2026.
• Historically, Price to Sales has averaged 32.08 across 5 years, with a median of 23.97 in 2024.
• The sharpest annual moves came in 2022 and 2023: Price to Sales surged 65.98% in 2022, then slumped 83.69% in 2023.
• Over 5 years, Price to Sales stood at 122.56 in 2022, then sank by 83.69% to 19.98 in 2023, then climbed by 22.0% to 24.38 in 2024, then plunged by 42.29% to 14.07 in 2025, then climbed by 5.85% to 14.89 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 14.89, 10.76, and 20.17 for Q3 2026, Q2 2026, and Q1 2026 respectively.